BMO Capital Markets reaffirmed its “Market Perform” rating on ARM Holdings, down 3.7%, with a target price of 995p. HSBC reissued its “Buy” rating on Johnson Matthey, down 2.8%, with a target price of 3700p. JPMorgan Chase reiterated its “Neutral” rating on Abcam, down 0.8%, with a target price of 487p.
Blinkx, up 12.3%, announced that it has completed the acquisition of All Media Network, LLC for an undisclosed amount.
Cyan Holdings, up 11.1%, stated that it installed its smart meter projects in India under a contract signed last year with Larsen & Toubro. Financial details of the transaction were not divulged.
Sagentia Group, up 2.1%, announced that it issued 5,000 treasury shares at a price of 80p per share in settlement of the exercise of share options.
Cambridge Cognition Holdings, up 1.8%, indicated that sales of Cantab Connect CTIS-Abuse Liability have surpassed £1 million in its first nine months from launch.
In its trading update for the year ended 27 March 2015, Sepura, up 0.4%, indicated that it projects to post adjusted EPS of 9.7c per share, matching market expectations and revenues of around €130 million, up 11% on an annual basis. Investec reissued its “Buy” rating on the stock with a target price of 200p.
LPA Group, down 0.7%, announced that WH Ireland Limited has been appointed as sole broker to the company.
Horizon Discovery Group, down 3.1%, announced that full year revenues increased sharply to £11.9m from £6.6m posted last year. However loss after tax for the period was £5.9m, wider than the previous year’s loss of £2.9m, as a result of trading and investment activity. Panmure Gordon raised its target price on the stock to 298p from 247p and maintained its “Buy” rating.
In its trading update for the three months ended 31 March 2015, Dialight, down 8.3%, indicated that demand for the company’s LED products within the lighting division remained robust and the group’s revenue growth surpasses Board’s forecast for the first quarter. Canaccord Genuity lowered its target price on the stock to 900p from 920p but maintained its “Buy” rating.
Sphere Medical Holding’s share price fell 5.1%, after indicating that its full year revenues declined to £14,000 from £40,000, while its operating loss widened to £5.9m from £5.7m. Separately, the company indicated that it is planning to raise £12m by placing 75 million new ordinary shares issued at 16p each to new and existing customer. The company also stated that it was considering a £1.2m capital raise via an open offer of 7,425,661 shares to qualifying shareholders.
UK markets ended on a weaker footing last week, amid ongoing concerns surrounding Greece’s debt. The FTSE 100 index lost 1.3% to 6,994.6, while the FTSE AIM 100 Index retreated 2.4% to finish at 3,408.2. The FTSE techMARK 100 Index edged 2.8% lower to 3,821.6.
US markets also closed lower over the week. The DJIA index declined 1.3% to 17,826.3, while the NASDAQ Index eased 1.3% to 4,931.8.
View the report in full
____________________________________________________